City

Seattle (2)

Arcadia (1)

Hackensack (1)

Pittsburgh (1)

Overall Status

Completed (4)

Phase

phase 1 (2)

n/a (1)

phase 2 (1)

Sponsor

Fred Hutchinson Cancer Center (2)

National Cancer Institute (NCI) (2)

Collaborator

National Cancer Institute (NCI) (1)

Study Documents

Intervention Type

drug (4)

other (3)

procedure (2)

radiation (1)

Funder Type

NIH (2)

Other (2)

Study Type

Interventional (4)

meningeal chronic myelogenous leukemia

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission

Completed

Hematopoietic/Lymphoid Cancer
+135 more

beclomethasone dipropionate
+4 more

Hackensack, New Jersey
+1 more

Feb 1, 2021

Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission

Completed

Has Results

Accelerated Phase Chronic Myelogenous Leukemia
+178 more

fludarabine phosphate
+5 more

Seattle, Washington

Fred Hutchinson Cancer Research Center/University of Washington

Apr 17, 2017

Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, AIDS-related Peripheral/Systemic Lymphoma Trial

Completed

Accelerated Phase Chronic Myelogenous Leukemia
+80 more

imatinib mesylate
pharmacological study

Pittsburgh, Pennsylvania

University of Pittsburgh

Feb 6, 2013

Accelerated Phase Chronic Myelogenous Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Childhood Chronic Myelogenous

Completed

Accelerated Phase Chronic Myelogenous Leukemia
+7 more

dasatinib
+2 more

Arcadia, California

Children's Oncology Group

Feb 4, 2013